Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
78 Cards in this Set
- Front
- Back
An Ab that can agglutinate RBCs (bind RBCs in a visible clump in a test tube) if such RBCs show the specific corresponding Ag on their membranes
|
Agglutinin
|
|
An Ab that can hemolyze RBCs (lyse RBCs thus causing the presence of a pink supernatant after centrifugation in a test tube) if such RBCs show the specific corresponding Ag on their membranes
|
Hemolysin
|
|
Complete Ab
|
An antibody that can coat AND directly agglutinate RBCs
|
|
Incomplete Ab
|
An antibody that can coat but CANNOT agglutinate RBCs
|
|
“warm” antibody
|
An antibody which, in vitro, reacts best at 37 ºC
|
|
“cold” antibody
|
An antibody which, in vitro, reacts best at 4 ºC to 10 ºC
|
|
The “thermal amplitude” of so-called antibodies is variable in vivo
|
cold much more then warm
|
|
which blood groups
a sustained high concentration of IgM with some formation of IgG after days or weeks is typical of a primary response while only a transient rise in IgM and a sustained IgG increase are typical of a secondary response |
all blood Group Antigens except ABO
|
|
“Coombs’ serum” aka
|
Antihuman globulin serum
|
|
Antihuman globulin serum aka
|
“Coombs’ serum”
|
|
goal of
Direct Coombs’ test |
To detect Ig (Ab) bound to the membrane of the patient’s RBCs
|
|
Direct Coombs’ test
wrt false positive |
Ab present “accidentally” on the patient’s RBCs (Ab transiently acquired through the transfusion of plasma or of other component, maternal Ab circulating in neonatal plasma
|
|
autocontrol
phases |
1 detection of "cold" Ab's mostly IgM
2 some “warm” antibodies mixture of Ab's and IgG 3 add antihuman globulin which allows detection of MOST warm Ab's 3 |
|
goal of
Indirect Coombs’ test |
To detect, in the patient’s serum, Ig (Ab) directed against an Ag seen on RBC membranes
|
|
Procedure
Direct Coombs’ test |
Wash the patient’s RBCs with saline then add antihuman globulin serum
|
|
An “auto-control” is similar to the
|
DAT
|
|
procedure for
Indirect Coombs’ test |
Like the auto test but
Mix “commercial” suspension(s) of RBCs with serum from patient at room T º |
|
It is the most commonly performed test in the transfusion service besides the tests to determine ABO Group and Rh Type
|
INDIRECT ANTIGLOBULIN TEST
|
|
The test serves as the basis for antibody screens and panel work-ups
|
INDIRECT ANTIGLOBULIN TEST
|
|
Elution
|
removing and/or detaching an antibody from the RBC membrane
|
|
Elution
why used |
The antibody is then tested against RBCs with known antigens on their membrane
|
|
ELUTION TECHNIQUES
|
Heat, freeze-thaw and chemical methods
|
|
PRACTICAL APPLICATIONS OF THE DAT
allo or auto |
Usually this test screens for auto-antibodies
|
|
PRACTICAL APPLICATIONSOF THE IAT
allo or auto |
Screens most usually for allo-antibodies
|
|
Hemolytic disease of the newborn
Patients with auto-immune disease what test to run |
PRACTICAL APPLICATIONS OF THE DAT
|
|
If no (further) transfusions are necessary: the ????? may be practically useless
|
DAT
|
|
PRACTICAL APPLICATIONSOF THE IAT
main uses |
Crossmatch: IAT-like test involving the patient’s serum and RBCs from a unit that is likely to be transfused to the patient
|
|
Immediate Spin Crossmatch
what is it |
If the “screen” is negative, the crossmatch is done through phase I only, and is called Immediate Spin Crossmatch
|
|
“Warm” auto-antibodies
which type |
Usually incomplete Ab (mostly IgG
|
|
70% of all auto-antibodies
warm or cold |
warm
|
|
30% of all auto-antibodies
|
“Cold
|
|
“Cold” auto-antibodies
what type |
Usually complete Ab (mostly IgM
|
|
CHROMOSOMAL LOCALIZATION OF BLOOD GROUP GENES
ABO |
9
|
|
CHROMOSOMAL LOCALIZATION OF BLOOD GROUP GENES
Rh |
1
|
|
CHROMOSOMAL LOCALIZATION OF BLOOD GROUP GENES
Kell |
7
|
|
CHROMOSOMAL LOCALIZATION OF BLOOD GROUP GENES
Kidd |
18
|
|
CHROMOSOMAL LOCALIZATION OF BLOOD GROUP GENES
Duffy |
1
|
|
CHROMOSOMAL LOCALIZATION OF BLOOD GROUP GENES
MNS |
4
|
|
H antigen only
|
type O
|
|
name the ABO
terminal sugar units |
H A B
|
|
is a weak A antigen
|
A2
|
|
which is more common A1 or A2
|
A1 80 to 20
|
|
What is the Bombay phenotype
|
Absence of H
|
|
The symbol used for the phenotype
|
Oh
|
|
The Bombay phenotype
Ab's |
Anti-A Anti-B Anti-A,B
Anti-H |
|
THE RHESUS SYSTEM
letters |
Dd
Cc Ee note, there is no d, it correspods to nothing |
|
Weak D: Historically wrt Tx
|
Treated as D positive (“Rh pos”) donor
Treated as D negative (“Rh neg”) recipient |
|
THE RHESUS SYSTEM
wrt single vs 3 genes |
Wiener system : single gene R
Fisher-Race system: three genes CDE |
|
KELL SYSTEM
the most important being |
K (ex-Kell) and k (ex-Cellano)
Alloantibodies to K are commonly seen Bc k is much more common KK=1% kk=91% |
|
KIDD SYSTEM
antigens |
Jka or Kidd (a) and Jkb or Kidd (b)
|
|
KIDD SYSTEM
antibodies |
Both anti-Jka and anti-Jkb are seen commonly
|
|
DUFFY SYSTEM
antigens |
Several antigens, most important:
Fya or Duffy(a) and Fyb or Duffy(b) |
|
MNS System
antigens |
Several antigens, most important:
M and N S and s |
|
Many clinical situations are associated with auto-antibodies, among which ??????? is the most frequent
|
auto-anti-D
|
|
Lymphocytes/HLA
which chromasome |
6
|
|
Class I antigens: Expressed by
|
all lymphocytes and many other cells
|
|
Class II antigens: Expressed by
|
B-cells and activated T-cells
|
|
HLA testing is important in
|
Transplantation (bone marrow, kidney)
Paternity testing Transfusion medicine (platelets) |
|
Transfusion of granulocytes
considerations |
Must be HLA-matched
Must be irradiated |
|
HPA: Human platelet antigen
groups |
5 groups (I-V)
|
|
HPA: Human platelet antigen: current classification
most important system |
HPA I (two alleles: HPA Ia and HPA Ib)
|
|
HPA: Human platelet antigen: current classification
when clinically significant |
N.A.I.T.P. (neonatal allo-immune thrombocytopenia)
|
|
Additional surrogate tests:
|
RPR or other for syphilis
ALT (SGPT |
|
Storage lesion of erythrocytes with ???? (reversible, and less significant when Additive Solutions are used)
|
potassium “leakage”
|
|
Storage lesion of platelets due to ?????
|
low pH, to insufficient mechanical or manual agitation, or to variations in temperature
|
|
PLT unit (shelf life
|
5 days
|
|
RBC unit in AS (shelf life of
|
42 days
|
|
FFP unit (shelf life of
|
1 year
|
|
Contraindications to transfuse erythrocytes
|
If anemia can be treated pharmacologically
If the patient has moderately to severely decompensated congestive heart failure |
|
Indications for RBC filtering
|
Prevention of:
Febrile Non-Hemolytic Transfusion Reactions (FNHTR) Allo-immunization to HLA CMV transmission or reactivation HTLV (not HIV) transmission |
|
indications of Irradiated RBC products
|
prevention of Transfusion-Associated Graft-Versus-Host Disease (TA-GVHD)
|
|
Contraindications to transfuse platelets
|
Idiopathic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura Heparin-Induced Thrombocytopenia / Thrombosis Syndrome Uremia |
|
Washed platelets:
Indicated to prevent |
IgA - anti IgA reactions
|
|
Irradiated platelets
why |
Indicated to prevent TA-GVHD
|
|
“Matched platelets”:
|
HLA-matching
HPA-matching Cross-matching |
|
TRANSFUSING GRANULOCYTES
when |
Granulocyte (neutrophil) count < 500
|
|
FFP contains
what factors |
all factors
|
|
“Cryo” contains
what factors |
I, VIII/vWF, XIII
|